C4 Therapeutics, Inc. earnings per share and revenue

CCCC earnings per share for the last quarter are -0.49 USD whereas the estimation was -0.49 USD which accounts for 0.62% surprise. Company revenue for the same period amounts to 5.18 M USD despite the estimated figure of 5.09 M USD. Estimated earnings per share for the next quarter are -0.46 USD, and revenue is expected to reach 4.74 M USD. Also watch annual changes over time to get a bigger picture of CCCC earnings per share and revenue dynamics.